ANDOVER, Mass. and MUNICH, Sept. 5, 2014 /PRNewswire/ -- Philips Respironics, a division of Royal Philips (NYSE: PHG, AEX: PHIA), will showcase its innovative range of sleep and respiratory disease management solutions at the European Respiratory Society (ERS) International Congress in Munich from 6-10 September, 2014.
Logo - http://photos.prnewswire.com/prnh/20140219/NE67640LOGO-b
At the ERS International Congress, Philips will exhibit sleep and respiratory innovations that span the continuum of care, helping healthcare professionals diagnose, titrate, treat and manage these disorders. The company's range of connected products and services, which demonstrate Philips' commitment to disease management throughout the entire care pathway, will be on display for physicians to experience firsthand.
"It is becoming increasingly important for healthcare professionals to have access to comprehensive solutions that enable them to monitor patient progress across the entire continuum of care," said Teofilo Lee-Chiong, M.D., Chief Medical Liaison, Philips Healthcare. "Philips understands the complex needs of both patients with sleep and breathing issues and their care providers."
Sleep-disordered breathing innovations across the continuum of care
"In a changing healthcare environment, physicians are finding it increasingly challenging to efficiently and cost-effectively diagnose and manage patients with complex sleep conditions," said Yann Goiot, Vice President Market Group Leader HHS, Healthcare EMEA. "With a complete, connected suite of sleep diagnostic and therapy products, Philips is serving the needs of healthcare professionals with efficient end-to-end innovations that identify, treat and manage sleep-disordered breathing while increasing compliance and adherence to therapy."
Diagnosis
Titration
Therapy
Patient Management
Mask options that promote quick acceptance and long-term use
Philips approaches innovation with an intimate understanding of the needs of those using our devices. Philips' new PAP mask line includes a nasal mask, full-face mask, and minimal-contact mask, which provides options to suit a patient's individual needs, leading to greater adoption of therapy and better long-term adherence.
Insights for better COPD care
Throughout the show, Philips will highlight key respiratory drug delivery, oxygen therapy and home ventilation innovations that are improving the management of chronic respiratory diseases. To better understand physician needs in this area, Philips will also conduct a COPD exacerbation prevention survey with willing physicians who visit the Philips booth.
Clinical updates from leaders in sleep and respiratory care
Philips will present a number of clinical updates and case studies during the show as well as video diaries that tell the stories of patients and physicians, highlighting Philips' vision for the future of healthcare.
Philips will conduct two educational workshops at ERS:
Visit Philips Respironics at B1_M02 at the 2014 European Respiratory Society International Congress, 6 to 10 September 2014, at Munich's ICM – Messe Munchen. For more information, visit www.philips.com/ers2014 and follow @PhilipsResp and the Philips Respironics Facebook page for updates from the show.
*preference data on file
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.